Abbreviation (ISO4): Acta Academiae Medicinae Sinicae
Editor in chief: Xuetao CAO
Acta Academiae Medicinae Sinicae >
Role of Mitophagy Affecting Macrophage Polarization in Immunomodulationin Sepsis and Traditional Chinese Medicine Intervention:A Review
Received date: 2023-09-15
Online published: 2024-12-03
sepsis,a syndrome characterized by organ dysfunction caused by infection,exhibits high incidence and mortality.the pathogenesis of sepsis is complex and involves a cascade of immune reactions,with no specific drugs currently available.sepsis is mainly treated with Western medical supportive therapies such as antibiotics,hemodynamic management,and mechanical ventilation.However,the occurrence of immune cascades significantly increases patients’vulnerability to secondary infections,leading to septic shock and unfavorable prognoses.International consensus indicates that initiating dynamic monitoring of patients’immune function within 48 h post-sepsis diagnosis can effectively decelerate sepsis progression.Extensive studies have indicated that macrophages,serving as the first line of defense in the innate immune system against pathogens,play a vital role in treating immune system disorders by regulating macrophage polarization and the ratio of cytokines activated.mitophagy,a hot topic in recent years,has increasingly been shown to play a crucial role in regulating inflammatory signal transduction.Promoting mitophagy during the stage of cytokine storm can mitigate uncontrolled infection and excessive inflammation in sepsis,and inhibiting mitophagy during immunosuppression can enhance host immunity,facilitate bacterial clearance,and improve the survival rate of patients.the idea of treating disease before its onset in traditional Chinese medicine(TCM)coincides with the current consensus among sepsis experts on prevention and interception.the TCM therapies such as extracts of Chinese medicine decoction pieces,TCM compound prescriptions,and acupuncture and moxibustion have the effects of clearing heat and detoxifying,activating blood and resolving stasis,reinforcing healthy qi and consolidating root,and purging.These approaches dynamically regulate the levels of mitophagy-related proteins,such as phosphatase and tension homology-induced putative kinase 1,Parkin-E3 ubiquitin protein ligase,light chain 3,and p62,while maintaining a suitable ratio between M1 and M2 macrophages.Consequently,they effectively prevent,halt,or even reverse the progression of sepsis,offering a novel perspective on sepsis management by emphasizing prevention before disease onset and controlling development of existing disease。
Luyao QI , Jixiang XING , Bingqing OUYANG , Yunfeng LI , Ming LEI . Role of Mitophagy Affecting Macrophage Polarization in Immunomodulationin Sepsis and Traditional Chinese Medicine Intervention:A Review[J]. Acta Academiae Medicinae Sinicae, 2024 , 46(5) : 720 -731 . DOI: 10.3881/j.issn.1000-503X.15849
图1 线粒体自噬的主要通路图ROS: reactive oxygen species; Δψm: mitochondrial membrane potential; PARKIN: Parkinson-E3 ubiquitin ligase; PINK1: phosphatase and tensin homolog inducible kinase 1; LC3: light chain 3; BNIP3: Bcl-2/adenovirus E1B-19 kDa interacting protein 3; NIX: BNIP3 analog; FUNDC1: FUN14 domain protein 1 |
图2 巨噬细胞极化诱导图LPS: lipopolysaccharide; Th1: T helper 1; IFN-γ: γ-interferon; TNF-α: tumor necrosis factor-α; IL: interleukin; TGF-β: transforming growth factor-β; iNOS: inducible nitric oxide synthase; TLR: Toll-like receptor; MHC-Ⅱ: major histocompatibility complex Ⅱ; CXCL9: chemokine CXC ligand 9; Arg-1: arginase 1; FIZZ1: resistin-like molecule α; VEGF: vascular endothelial growth factor; CCL: chemokine ligand; NF-κB: nuclear factor-κB; STAT: signal transducer and activator of transcription; IRF: interferon regulatory factor; JMJD3: Jumonji domain-containing protein 3; PPAR: peroxisome proliferator-activated receptor |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
中国医疗保健国际交流促进会急诊医学分会, 中华医学会急诊医学分会, 中国医师协会急诊医师分会, 等. 中国脓毒症早期预防与阻断急诊专家共识[J]. 中华急诊医学杂志, 2020, 29(7):885-895.DOI:10.3760/cma.j.issn.1671-0282.2020.07.001.
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
|
[32] |
|
[33] |
|
[34] |
|
[35] |
|
[36] |
|
[37] |
|
[38] |
|
[39] |
|
[40] |
|
[41] |
中国中西医结合学会急救医学专业委员会,《中国中西医结合急救杂志》编辑委员会. 脓毒性休克中西医结合诊治专家共识[J]. 中华危重病急救医学, 2019, 31(11):1317-1323.DOI:10.3760/cma.j.issn.2095-4352.2019.11.002.
|
[42] |
刘清泉. 实用中医急诊学[M]. 北京: 中国中医药出版社, 2020:311-321.
|
[43] |
侯昕玥. 中医适宜技术耳穴压丸联合揿针防控不同阶段近视的疗效评价研究[D]. 北京: 中国中医科学院, 2022.
|
[44] |
胡梦玲, 任小巧, 范佳佳, 等. 基于中风病不同阶段热毒与炎症反应相关性探讨中医药防治中风思路[J]. 环球中医药, 2021, 14(10):1846-1849.DOI:10.3969/j.issn.1674-1749.2021.10.026.
|
[45] |
陈玄, 陈娟, 谢丽华, 等. 骨碎补-续断药对对成骨/破骨代谢的双向调控作用及其对Hif1a基因的影响[J]. 中国骨质疏松杂志, 2023, 29(1):64-69.DOI:10.3969/j.issn.1006-7108.2023.01.012.
|
[46] |
|
[47] |
|
[48] |
王霞蓉, 王毅, 程翼宇, 等. 中药单体成分局部给药及其促进吸收方法的研究进展[J]. 中国药科大学学报, 2016, 47(3):368-376.DOI:10.11665/j.issn.1000-5048.20160321.
|
[49] |
|
[50] |
|
[51] |
|
[52] |
|
[53] |
林世翼, 贾景明, 王安华. 狼毒二萜类化学成分及其药理作用研究进展[J]. 中草药, 2020, 51(1):256-264.DOI:10.7501/j.issn.0253-2670.2020.01.033.
|
[54] |
|
[55] |
曾金, 张志荣, 缪萍, 等. 隐丹参酮的药理作用研究进展[J]. 中成药, 2015, 37(6):1309-1313.DOI:10.3969/j.issn.1001-1528.2015.06.033.
|
[56] |
|
[57] |
|
[58] |
|
[59] |
|
[60] |
|
[61] |
|
[62] |
|
[63] |
王小强, 杨思进, 白雪, 等. 基于玄府理论整合中药复方加中药单体的配伍思想[J]. 中医杂志, 2019, 60(9):804-807.DOI:10.13288/j.11-2166/r.2019.09.020.
|
[64] |
路立峰, 张媛媛, 李振兴, 等. 葛根芩连汤药效物质基础及质量控制研究进展[J]. 中成药, 2022, 44(10):3239-3243.DOI:10.3969/j.issn.1001-1528.2022.10.029.
|
[65] |
|
[66] |
|
[67] |
|
[68] |
|
[69] |
|
[70] |
|
[71] |
王蕴涵, 杜群, 李燕舞, 等. 大承气汤治疗急性肺损伤的主要活性成分及潜在靶点研究[J]. 广州中医药大学学报, 2021, 38(12):2757-2764.DOI:10.13359/j.cnki.gzxbtcm.2021.12.034.
|
[72] |
刘宇寒. 大承气汤通过VDR调节细胞焦亡与自噬减轻脓毒症肺损伤的机制研究[D]. 武汉: 华中科技大学, 2022.
|
[73] |
|
[74] |
钟旋, 李袁袁, 林荣锋, 等. 大承气汤对肠源性脓毒症小鼠的保护作用及机制[J]. 中国药房, 2023, 34(17):2101-2106.DOI:10.6039/j.issn.1001-0408.2023.17.10.
|
[75] |
|
[76] |
|
[77] |
|
[78] |
|
[79] |
|
[80] |
|
[81] |
|
[82] |
耿欢, 孙芳园, 卢明, 等. 肠三针介导TRPV1/CGRP信号通路对脓毒症肠道菌群紊乱影响[J]. 辽宁中医药大学学报, 2022, 24(4):80-83.DOI:10.13194/j.issn.1673-842x.2022.04.018.
|
[83] |
|
[84] |
|
[85] |
|
[86] |
|
[87] |
|
[88] |
|
[89] |
|
[90] |
|
[91] |
|
[92] |
|
[93] |
|
[94] |
|
[95] |
|
[96] |
|
[97] |
|
[98] |
|
/
〈 |
|
〉 |